Maternal and neonatal pneumococcal vaccination - where are we now?

References

• Rajaratnam JK, Marcus JR, Flaxman AD, et al. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards millennium development goal 4. Lancet. 2010;375(9730):1988–2008.
   PubMed Web of Science ®Google Scholar
• Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151–2161.
   PubMed Web of Science ®Google Scholar
• UNDP. Post-2015 development agenda. [ cited 2015 May 11]. Available from: http://www.undp.org/content/undp/en/home/mdgoverview/mdg_goals/post-2015-development-agenda.html.
   Google Scholar
• United Nations General Assembly Seventieth Session. Transforming our world: The 2030 agenda for sustainable development. 2015; Available from: http://www.un.org/ga/search/view_doc.asp?symbol=A/70/L.1&Lang=E.
   Google Scholar
• O’Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902.
   PubMed Web of Science ®Google Scholar
• Hill PC, Cheung YB, Akisanya A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis. 2008;46(6):807–814.
   PubMed Web of Science ®Google Scholar
• Roca A, Hill PC, Townend J, et al. Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med. 2011;8(10):e1001107.
   PubMed Web of Science ®Google Scholar
• Coles CL, Labrique A, Saha SK, et al. Newborn vitamin A supplementation does not affect nasopharyngeal carriage of Streptococcus pneumoniae in Bangladeshi infants at age 3 months. J Nutr. 2011;141(10):1907–1911.
   PubMed Web of Science ®Google Scholar
• Coles CL, Rahmathullah L, Kanungo R, et al. Vitamin A supplementation at birth delays pneumococcal colonization in South Indian infants. J Nutr. 2001;131(2):255–261.
   PubMed Web of Science ®Google Scholar
• Leach AJ, Boswell JB, Asche V, et al. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J. 1994;13(11):983–989.
   PubMed Web of Science ®Google Scholar
• Simell B, Auranen K, Kayhty H, et al. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11(7):841–855.
   PubMed Web of Science ®Google Scholar
• Waters D, Jawad I, Ahmad A, et al. Aetiology of community-acquired neonatal sepsis in low and middle income countries. J Glob Health. 2011;1(2):154–170.
   PubMedGoogle Scholar
• Swann O, Everett DB, Furyk JS, et al. Bacterial meningitis in malawian infants <2 months of age: etiology and susceptibility to world health organization first-line antibiotics. Pediatr Infect Dis J. 2014;33(6):560–565.
   PubMed Web of Science ®Google Scholar
• Mulholland EK, Ogunlesi OO, Adegbola RA, et al. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J. 1999;18(10 Suppl):S35–41.
   PubMed Web of Science ®Google Scholar
• WHO. Chronic suppurative otitis media - burden of illness and management options. 2004. Geneva: WHO.
   Google Scholar
• Binks MJ, Moberley SA, Balloch A, et al. PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia. Vaccine. 2015;33(48):6579–6587.
   PubMed Web of Science ®Google Scholar
• Wiertsema SP, Leach AJ. Theories of otitis media pathogenesis, with a focus on Indigenous children. Med J Aust. 2009;191(9 Suppl):S50–S54.
   PubMed Web of Science ®Google Scholar
• Progress in introduction of pneumococcal conjugate vaccine worldwide, 2000-2012. Wkly Epidemiol Rec. 2013;88(17):173–180.
   PubMedGoogle Scholar
• WHO. Pneumococcal vaccines - Pneumococcal position paper - 2012. Wkly Epidemiol Rec. 2012;87(14):129–144.
   PubMedGoogle Scholar
• Whitney CG, Goldblatt D, O’Brien KL. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers. Pediatr Infect Dis J. 2014;33(Suppl 2):S172–S181.
   PubMed Web of Science ®Google Scholar
• Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014;33(Suppl 2):S161–71.
   PubMed Web of Science ®Google Scholar
• Garcia Gabarrot G, Lopez Vega M, Perez Giffoni G, et al. Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country. PLoS One. 2014;9(11):e112337.
   PubMed Web of Science ®Google Scholar
• Von Gottberg A, De Gouveia L, Tempia S, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014;371(20):1889–1899.
   PubMed Web of Science ®Google Scholar
• Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006;295(14):1668–1674.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Andrews NJ, Waight P, et al. Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and Wales. Clin Infect Dis. 2013;56(5):633–640.
   PubMed Web of Science ®Google Scholar
• Hammitt LL, Akech DO, Morpeth SC, et al. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health. 2014;2(7):e397–e405.
   PubMed Web of Science ®Google Scholar
• Egere U, Townend J, Roca A, et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial. PLoS One. 2012;7(11):e49143.
   PubMed Web of Science ®Google Scholar
• Advisory committee on immunization practices. Preventing pneumococcal disease amongst infants and young children: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2000;49(RR–9):1–35.
   Google Scholar
• Cheung YB, Zaman SM, Nsekpong ED, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr Infect Dis J. 2009;28(11):990–995.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Millar EV, Zell ER, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis. 2007;196(8):1211–1220.
   PubMed Web of Science ®Google Scholar
• Roca A, Bottomley C, Hill PC, et al. Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage. Clin Infect Dis. 2012;55(6):816–824.
   PubMed Web of Science ®Google Scholar
• Choi YH, Melegaro A, Van Hoek AJ, et al.. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in different countries - mathematical modelling study. Pneumonia. 2014. ISPPD Abstract 0505.
   Google Scholar
• Klugman KP. Herd protection induced by pneumococcal conjugate vaccine. Lancet Glob Health. 2014;2(7):e365–6.
   PubMed Web of Science ®Google Scholar
• Mackenzie GA, Hill PC, Jeffries DJ, et al. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study. Lancet Infect Dis. 2016.
   Google Scholar
• Englund JA. Introduction. Maternal immunization - Promises and concerns. Vaccine. 2015;33(47):6372–6373.
   PubMed Web of Science ®Google Scholar
• O’Dempsey TJ, McArdle T, Ceesay SJ, et al. Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy. Vaccine. 1996;14(10):963–970.
   PubMed Web of Science ®Google Scholar
• Obaro SK, Deubzer HE, Newman VO, et al. Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy. Pediatr Infect Dis J. 2004;23(11):1023–1029.
   PubMed Web of Science ®Google Scholar
• Deubzer HE, Obaro SK, Newman VO, et al. Colostrum obtained from women vaccinated with pneumococcal vaccine during pregnancy inhibits epithelial adhesion of Streptococcus pneumoniae. J Infect Dis. 2004;190(10):1758–1761.
   PubMed Web of Science ®Google Scholar
• Lehmann D, Pomat WS, Combs B, et al. Maternal immunization with pneumococcal polysaccharide vaccine in the highlands of Papua New Guinea. Vaccine. 2002;20(13–14):1837–1845.
   PubMed Web of Science ®Google Scholar
• Quiambao BP, Nohynek HM, Kayhty H, et al. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine. 2007;25(22):4470–4477.
   PubMed Web of Science ®Google Scholar
• Quiambao BP, Nohynek H, Kayhty H, et al. Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines. Vaccine. 2003;21(24):3451–3454.
   PubMed Web of Science ®Google Scholar
• Holmlund E, Nohynek H, Quiambao B, et al. Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination. Vaccine. 2011;29(28):4565–4575.
   PubMed Web of Science ®Google Scholar
• Munoz FM, Englund JA, Cheesman CC, et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine. 2001;20(5–6):826–837.
   PubMed Web of Science ®Google Scholar
• Daly KA, Scott Giebink G, Lindgren BR, et al. Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media. Vaccine. 2014;32(51):6948–6955.
   PubMed Web of Science ®Google Scholar
• Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555–1564.
   PubMed Web of Science ®Google Scholar
• Schlaudecker EP, Steinhoff MC, Omer SB, et al. Antibody persistence in mothers one year after pneumococcal immunization in pregnancy. Vaccine. 2012;30(34):5063–5066.
   PubMed Web of Science ®Google Scholar
• Lopes CR, Berezin EN, Ching TH, et al. Ineffectiveness for infants of immunization of mothers with pneumococcal capsular polysaccharide vaccine during pregnancy. Braz J Infect Dis. 2009;13(2):104–106.
   PubMed Web of Science ®Google Scholar
• Lopes CC, Berezin EN, Scheffer D, et al. Pneumococcal nasopharyngeal carriage in infants of mothers immunized with 23V non-conjugate pneumococcal polysaccharide vaccine. J Trop Pediatr. 2012;58(5):348–352.
   PubMed Web of Science ®Google Scholar
• Almeida Vde C, Mussi-Pinhata MM, De Souza CB, et al. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants. Vaccine. 2009;27(29):3856–3861.
   PubMed Web of Science ®Google Scholar
• Shahid NS, Steinhoff MC, Hoque SS, et al. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet. 1995;346(8985):1252–1257.
   PubMed Web of Science ®Google Scholar
• Borrow R, Heath PT, Siegrist CA. Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr Opin Infect Dis. 2012;25(3):292–303.
   PubMed Web of Science ®Google Scholar
• Jones C, Pollock L, Barnett SM, et al. Specific antibodies against vaccine-preventable infections: a mother-infant cohort study. BMJ Open. 2013;3(4):e002473–e002473.
   Web of Science ®Google Scholar
• De Voer RM, Van Der Klis FR, Nooitgedagt JE, et al. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis. Clin Infect Dis. 2009;49(1):58–64.
   PubMed Web of Science ®Google Scholar
• Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21(24):3365–3369.
   PubMed Web of Science ®Google Scholar
• Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol. 1986;63(1):127–134.
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Hum Vaccin Immunother. 2013;9(12):2505–2523.
   PubMed Web of Science ®Google Scholar
• Palmeira P, Quinello C, Silveira-Lessa AL, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012;2012:1–13.
   Google Scholar
• Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines. 2011;10(3):307–322.
   PubMed Web of Science ®Google Scholar
• Scott JA, Ojal J, Ashton L, et al. Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection. Clin Infect Dis. 2011;53(7):663–670.
   PubMed Web of Science ®Google Scholar
• Chaithongwongwatthana S, Yamasmit W, Limpongsanurak S, et al. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev. 2015;1:CD004903.
   PubMedGoogle Scholar
• Pomat WS, Van Den Biggelaar AH, Phuanukoonnon S, et al. Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in papua new guinean children: a randomised controlled trial. PLoS One. 2013;8(2):e56698.
   PubMed Web of Science ®Google Scholar